Refuge Biotech scores $25M from Chinese backers for CAR-T by Amirah Al Idrus Wednesday, May 2, 2018 Refuge's platform generates cells "that are programmed to make cancer-fighting decisions inside the patient's body."
NuProbe bags cash to enable early detection of cancer by Nick Paul Taylor Wednesday, April 25, 2018 The Sino-American startup thinks it can detect cell-free DNA in blood plasma and thereby enable screening for early-stage disease.
Adagene bags $50M to take anticancer antibodies into the clinic by Nick Paul Taylor Tuesday, March 27, 2018 The investment positions the Chinese antibody discovery shop to move the most advanced assets in its oncology pipeline into human testing.
MedGenome brings series C haul up to $40M by Nick Paul Taylor Monday, March 5, 2018 The genetic diagnostics business will use the cash to increase access to its tests outside of India’s biggest cities.
Sequoia, Google, Tencent fund AI biotech XtalPi's $15M series B by Angus Liu Thursday, January 25, 2018 XtalPi combines AI, quantum physics and cloud computing to predict drugs’ crystal structures more quickly and accurately.
WuXi NextCODE raises $240M to build genomics business by Nick Paul Taylor Friday, September 8, 2017 The investment sets the genomics company up to build out its platform and strike diagnostics partnerships to grow its user base and data repository.
Sands, Sequoia lead precision oncology player to $27.4M Series B round by Nick Paul Taylor Wednesday, August 31, 2016 Sands Capital Ventures and Sequoia India have led precision oncology player Mitra Biotech to a $27.4 million Series B round.
Sequoia-backed genomics startup, others face who-pays hurdle by John Carroll Friday, March 29, 2013 Despite some technological and initial financing feats under their belts, young software and bioinformatics outfits need to answer some key questions. For example, who pays?
